• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板、单核细胞和血浆中因子 XIII A 亚基的造血起源。来自骨髓移植研究的证据。

Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies.

作者信息

Poon M C, Russell J A, Low S, Sinclair G D, Jones A R, Blahey W, Ruether B A, Hoar D I

机构信息

Department of Medicine, University of Calgary, Alberta, Canada.

出版信息

J Clin Invest. 1989 Sep;84(3):787-92. doi: 10.1172/JCI114237.

DOI:10.1172/JCI114237
PMID:2569478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC329720/
Abstract

Factor XIII A subunit (FXIIIA) is found in plasma, platelets, and monocytes. The hemopoietic contributions to FXIIIA in these components were studied in patients transplanted with marrows from donors with different FXIIIA phenotypes. In three patients with successful engraftment (by DNA genotyping, red cell phenotyping, and cytogenetic studies) platelet and monocyte FXIIIA changed to donor phenotypes with hematologic recovery. Thus, FXIIIA in platelets and monocytes is synthesized de novo and/or from their progenitor cells. Plasma FXIIIA phenotype change after transplantation was more complex. Patient I changed from phenotype 1-1 (one electrophoretically fast band) to 1-2 (three bands) in 115 d; patients 2 and 3 did not change completely from phenotype 1-2 to 1-1 in up to 458 d, but did show enrichment of the fastest band. Thus, while there is a definite contribution of donor hemopoiesis to plasma FXIIIA, another source of recipient FXIIIA appears to be present to delay or prevent the phenotype change.

摘要

凝血因子 XIII A 亚基(FXIIIA)存在于血浆、血小板和单核细胞中。我们在接受了具有不同 FXIIIA 表型供体骨髓移植的患者中,研究了这些成分中造血系统对 FXIIIA 的贡献。在三名移植成功的患者中(通过 DNA 基因分型、红细胞表型分析和细胞遗传学研究),随着血液学恢复,血小板和单核细胞中的 FXIIIA 转变为供体表型。因此,血小板和单核细胞中的 FXIIIA 是重新合成的,和/或来源于它们的祖细胞。移植后血浆 FXIIIA 表型的变化更为复杂。患者 1 在 115 天内从表型 1-1(一条电泳快带)转变为 1-2(三条带);患者 2 和 3 在长达 458 天的时间里没有完全从表型 1-2 转变为 1-1,但确实显示出最快迁移条带的富集。因此,虽然供体造血系统对血浆 FXIIIA 有明确贡献,但受体 FXIIIA 的另一个来源似乎存在,从而延迟或阻止了表型变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/060691ff71c8/jcinvest00484-0068-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/68a361bed641/jcinvest00484-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/93c1dbbcb619/jcinvest00484-0067-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/060691ff71c8/jcinvest00484-0068-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/68a361bed641/jcinvest00484-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/93c1dbbcb619/jcinvest00484-0067-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e107/329720/060691ff71c8/jcinvest00484-0068-a.jpg

相似文献

1
Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies.血小板、单核细胞和血浆中因子 XIII A 亚基的造血起源。来自骨髓移植研究的证据。
J Clin Invest. 1989 Sep;84(3):787-92. doi: 10.1172/JCI114237.
2
Coagulation factor XIII A and B subunits in bone marrow and liver transplantation.骨髓和肝移植中的凝血因子XIII A亚基和B亚基
Transplantation. 1987 Jan;43(1):151-3. doi: 10.1097/00007890-198701000-00032.
3
Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.非处理单倍体相合造血干细胞移植后血液系统恶性肿瘤患者的血小板植入:CD34+细胞剂量和疾病状态的影响
Biol Blood Marrow Transplant. 2009 May;15(5):632-8. doi: 10.1016/j.bbmt.2009.02.001.
4
The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.未处理的单倍体相合造血干细胞移植后,CD34+细胞剂量对儿科患者血小板植入的影响。
Pediatr Blood Cancer. 2009 Dec;53(6):1100-6. doi: 10.1002/pbc.22159.
5
Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia.
Bone Marrow Transplant. 1996 Aug;18(2):319-24.
6
Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.影响T细胞去除的骨髓移植后中性粒细胞和血小板重建的因素:生长因子类型的不同作用及CD34(+)细胞剂量的作用
Bone Marrow Transplant. 2001 Apr;27(8):791-800. doi: 10.1038/sj.bmt.1702872.
7
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.自体骨髓移植后,先使用白细胞介素-3,再使用粒细胞巨噬细胞集落刺激因子治疗移植延迟。
Exp Hematol. 1993 Mar;21(3):405-410.
8
Hemopoietic reconstitution after bone marrow transplantation.
Exp Hematol. 1986 May;14(4):271-7.
9
Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.急性髓系白血病患者骨髓间质液中的肿瘤坏死因子α和脂联素会抑制正常造血。
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6793-9. doi: 10.1158/1078-0432.CCR-05-1033.
10
Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.先天性缺乏血浆因子XIII的患者的单核细胞缺乏因子XIII亚基a抗原和转谷氨酰胺酶活性。
Thromb Haemost. 1988 Apr 8;59(2):231-5.

引用本文的文献

1
Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer.凝血因子 XIII A 亚基是恶性实体瘤尤其是非小细胞肺癌治疗效果和预后的生物标志物。
Front Oncol. 2021 Dec 15;11:719085. doi: 10.3389/fonc.2021.719085. eCollection 2021.
2
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients.重症监护病房中住院的新冠肺炎患者的凝血因子 XIII 活性水平较低。
Thromb J. 2021 Nov 4;19(1):79. doi: 10.1186/s12959-021-00333-3.
3
Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation.

本文引用的文献

1
PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.各种疾病中的血浆纤维蛋白稳定因子活性
Blood. 1964 May;23:669-78.
2
Human factor XIII: fibrin-stabilizing factor.人凝血因子 XIII:纤维蛋白稳定因子。
Prog Hemost Thromb. 1980;5:245-90.
3
Coagulation factor XIII: a useful polymorphic genetic marker.凝血因子 XIII:一种有用的多态性遗传标记。
单核细胞暴露因子ⅩⅢ - A并稳定血栓以抵抗纤维蛋白溶解降解。
Int J Mol Sci. 2021 Jun 19;22(12):6591. doi: 10.3390/ijms22126591.
4
Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.凝血因子 XIII-A:止血和伤口愈合中不可或缺的“因子”
Int J Mol Sci. 2021 Mar 17;22(6):3055. doi: 10.3390/ijms22063055.
5
A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology.逆流而上:无细胞血浆中血小板特异性基因的波动,作为使用 RNA 测序来提高对损伤后血小板生物学理解的概念验证。
J Trauma Acute Care Surg. 2020 Jun;88(6):742-751. doi: 10.1097/TA.0000000000002681.
6
Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.皮肤中的因子 XIII 亚单位 A:在诊断和治疗中的应用。
Biomed Res Int. 2017;2017:3571861. doi: 10.1155/2017/3571861. Epub 2017 Aug 15.
7
Cre/lox Studies Identify Resident Macrophages as the Major Source of Circulating Coagulation Factor XIII-A.Cre/lox研究确定组织驻留巨噬细胞是循环凝血因子XIII-A的主要来源。
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1494-1502. doi: 10.1161/ATVBAHA.117.309271. Epub 2017 Jun 8.
8
Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.缺乏因子 XIII-A 转谷氨酰胺酶的小鼠在高脂肪饮食下表现出代谢健康肥胖的迹象。
Sci Rep. 2016 Oct 19;6:35574. doi: 10.1038/srep35574.
9
Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts.细胞因子XIIIA转谷氨酰胺酶定位于小窝,并调节成骨细胞中小窝蛋白-1的磷酸化、同型寡聚化和c-Src信号传导。
J Histochem Cytochem. 2015 Nov;63(11):829-41. doi: 10.1369/0022155415597964. Epub 2015 Jul 31.
10
Characterization of coagulation factor synthesis in nine human primary cell types.鉴定九种人原代细胞中凝血因子的合成。
Sci Rep. 2012;2:787. doi: 10.1038/srep00787. Epub 2012 Nov 9.
Hum Genet. 1984;67(2):132-5. doi: 10.1007/BF00272987.
4
Localisation of factor XIII in human tissues using an immunoperoxidase technique.利用免疫过氧化物酶技术对人组织中因子XIII进行定位。
J Clin Pathol. 1984 May;37(5):560-3. doi: 10.1136/jcp.37.5.560.
5
Fluorodeoxyuridine synchronization of bone marrow cultures.
Cancer Genet Cytogenet. 1983 Feb;8(2):123-32. doi: 10.1016/0165-4608(83)90044-4.
6
The gene for coagulation factor XIII a subunit (F13A) is distal to HLA on chromosome 6.凝血因子 XIII a 亚基(F13A)基因位于 6 号染色体上 HLA 的远端。
Hum Genet. 1984;67(4):406-8. doi: 10.1007/BF00291400.
7
Immunologic studies of proteins associated with subcellular fractions of normal human platelets.与正常人血小板亚细胞组分相关的蛋白质的免疫学研究。
J Lab Clin Med. 1967 Apr;69(4):651-8.
8
Factor XIII in human plasma and platelets.人血浆和血小板中的凝血因子 XIII
J Clin Invest. 1969 May;48(5):940-6. doi: 10.1172/JCI106053.
9
Evidence concerning the origin of liver macrophages.关于肝巨噬细胞起源的证据。
Br J Exp Pathol. 1971 Feb;52(1):88-99.
10
Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.用同位素法测定因子 XIII。I. 血浆、血清、白细胞、红细胞和血小板中的因子 XIII(转酰胺酶)以及凝块溶解度筛查试验的评估
Br J Haematol. 1970 Apr;18(4):399-410. doi: 10.1111/j.1365-2141.1970.tb01453.x.